NCT05700448 2026-02-05Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell LymphomaCStone PharmaceuticalsPhase 3 Not yet recruiting150 enrolled
NCT02085655 2021-03-15PEG-ASP+Gemox Regimen and Thalidomide for NK/T LymphomaSun Yat-sen UniversityPhase 3 Unknown264 enrolled
NCT02359162 2018-05-09Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early StageSun Yat-sen UniversityPhase 3 Terminated50 enrolled